The global epidemiology of hepatocellular carcinoma: present and future

Clin Liver Dis. 2011 May;15(2):223-43, vii-x. doi: 10.1016/j.cld.2011.03.006.

Abstract

The global risk of hepatocellular carcinoma (HCC) has been largely driven by hepatitis B virus (HBV) infection for the past century, along with hepatitis C virus (HCV), aflatoxin, excessive alcohol consumption, and obesity/diabetes. The dominant effect of HBV on global HCC risk should decline as the population vaccinated against HBV grows older. Infection with HCV is also expected to decline. Projections of HCV-related HCC rates remaining high for another 30 years may be overly pessimistic. Alcohol may be less of a factor in HCC in coming years. However, obesity and diabetes may become even more important risk factors for HCC.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Carcinoma, Hepatocellular / epidemiology*
  • Female
  • Hepatitis B, Chronic / epidemiology
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Incidence
  • Liver Neoplasms / epidemiology*
  • Male